Structure |
Chemical Name |
CAS |
MF |
![4,5-ジヒドロ-Α-(ヒドロキシメチル)-Α,3-ジメチル-5-オキソ-1-フェニル-1H-ピラゾール-4-メタンスルホン酸](/CAS/GIF/1242471-40-4.gif) |
4,5-ジヒドロ-Α-(ヒドロキシメチル)-Α,3-ジメチル-5-オキソ-1-フェニル-1H-ピラゾール-4-メタンスルホン酸 |
1242471-40-4 |
C13H16N2O5S |
![16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers)](/CAS/GIF/1040085-99-1.gif) |
16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers) |
1040085-99-1 |
C25H34O6 |
![2-ブロモ-1-シクロプロピル-2-(3-フルオロフェニル)エタノン](/CAS/GIF/1359829-72-3.gif) |
2-ブロモ-1-シクロプロピル-2-(3-フルオロフェニル)エタノン |
1359829-72-3 |
C11H10BrFO |
![N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide](/CAS/20150408/GIF/198471-06-6.gif) |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
198471-06-6 |
C18H16N2O4S |
![N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide](/CAS/20150408/GIF/289472-81-7.gif) |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
![(Z)-N-(2-nitrovinyl)acetaMide](/CAS/GIF/1238305-24-2.gif) |
(Z)-N-(2-nitrovinyl)acetaMide |
1238305-24-2 |
C4H6N2O3 |
![cefoxitin iMpurity B](/) |
cefoxitin iMpurity B |
|
|
![pidotiMod iMpurity A](/) |
pidotiMod iMpurity A |
|
|
![Rivaroxaban iMpurity A](/CAS/20180906/GIF/931204-39-6.gif) |
Rivaroxaban iMpurity A |
931204-39-6 |
C19H20ClN3O6S |
![R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester](/CAS/20150408/GIF/1268719-66-9.gif) |
R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester |
1268719-66-9 |
C19H22FN3O4 |
![Ticagrelor Sulfone](/CAS/20150408/GIF/274693-39-9.gif) |
Ticagrelor Sulfone |
274693-39-9 |
C23H28F2N6O6S |
![DesvancosaMinyl VancoMycin](/CAS/20210111/GIF/101485-50-1.gif) |
DesvancosaMinyl VancoMycin |
101485-50-1 |
C59H62Cl2N8O22 |
![アセトロール](/CAS/GIF/57898-80-3.gif) |
アセトロール |
57898-80-3 |
C14H22N2O3 |
![RAC-クロピドグレル-MP ENDO誘導體](/CAS/GIF/1346598-12-6.gif) |
RAC-クロピドグレル-MP ENDO誘導體 |
1346598-12-6 |
C25H26ClNO6S |
![1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine](/CAS/20140608/GIF/CB82544399.gif) |
1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine |
1331637-48-9 |
C11H22N6O4S2 |
![2′,3′-ジデオキシ-3′-チアシチジン](/CAS/20150408/GIF/134680-32-3.gif) |
2′,3′-ジデオキシ-3′-チアシチジン |
134680-32-3 |
C8H11N3O3S |
![Formoterol O-β-D-Glucuronide](/CAS/GIF/615551-59-2.gif) |
Formoterol O-β-D-Glucuronide |
615551-59-2 |
C25H32N2O10 |
![Mono-POC Tenofovir 6-Isopropyl CarbaMate](/CAS/GIF/1244022-56-7.gif) |
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
![Ropivacaine Impurity 6](/) |
Ropivacaine Impurity 6 |
|
|
![Solifenacin ring opening Impurity 11](/) |
Solifenacin ring opening Impurity 11 |
|
|
![Sugammadex sodium Org210839-1 Impurity](/) |
Sugammadex sodium Org210839-1 Impurity |
|
|
![Sugammadex sodium Org284426-1 Impurity](/) |
Sugammadex sodium Org284426-1 Impurity |
|
|
![Bendamustine Related Impurity 6](/) |
Bendamustine Related Impurity 6 |
|
|
![Butyphthalide impurity 39](/CAS/20200515/GIF/1841089-57-3.gif) |
Butyphthalide impurity 39 |
1841089-57-3 |
C24H28O4 |
![Butyphthalide impurity 45](/) |
Butyphthalide impurity 45 |
|
|
![Dapoxetine impurity 18](/) |
Dapoxetine impurity 18 |
|
|
![Febuxostat Impurity 76](/) |
Febuxostat Impurity 76 |
|
|
![Febuxostat Impurity 91](/) |
Febuxostat Impurity 91 |
|
|
![Ipratropium Bromide Impurity 1](/CAS/20200119/GIF/CB04842381.gif) |
Ipratropium Bromide Impurity 1 |
|
C20H29Br2NO3 |
![Lenvatinib Impurity 18](/) |
Lenvatinib Impurity 18 |
|
|
![Moxifloxacin Impurity 44](/CAS/20210111/GIF/1048972-52-6.gif) |
Moxifloxacin Impurity 44 |
1048972-52-6 |
C14H12FNO5 |
![Nintedanib Impurity 32](/) |
Nintedanib Impurity 32 |
|
|
![Olsalazine Impurity C](/) |
Olsalazine Impurity C |
|
|
![Parecoxib sodium Impurity 33](/) |
Parecoxib sodium Impurity 33 |
|
|
![Tofacitinib Impurity 96](/) |
Tofacitinib Impurity 96 |
|
|
![Vildagliptin Impurity ZA5](/) |
Vildagliptin Impurity ZA5 |
|
|
![Linagliptin Impurity CD10925](/) |
Linagliptin Impurity CD10925 |
|
|
![Nintedanib Impurity N](/) |
Nintedanib Impurity N |
|
|
![(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/CAS/20200119/GIF/1079083-63-8.gif) |
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
1079083-63-8 |
C27H29ClO10 |
![Vildagliptin Impurity 25](/CAS/20200611/GIF/1563006-28-9.gif) |
Vildagliptin Impurity 25 |
1563006-28-9 |
C7H10N2O2 |
![N-Methyl Iso Desloratadine](/CAS/GIF/183198-48-3.gif) |
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
![酒石酸イソプロピルエステル](/CAS/GIF/116601-09-3.gif) |
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
![Vardenafil Acetyl Analogue](/CAS/GIF/1261351-28-3.gif) |
Vardenafil Acetyl Analogue |
1261351-28-3 |
C25H34N6O3 |
![fenofibrate iMpurity](/) |
fenofibrate iMpurity |
|
|
![11-O-メチルクラリスロマイシン](/CAS/GIF/81103-14-2.gif) |
11-O-メチルクラリスロマイシン |
81103-14-2 |
C39H71NO13 |
![りん酸ENT-オセルタミビル](/CAS/GIF/1035895-89-6.gif) |
りん酸ENT-オセルタミビル |
1035895-89-6 |
C16H29N2O8P |
![3-cyano-4-isobutoxybenzaMide](/CAS/20150408/GIF/161718-85-0.gif) |
3-cyano-4-isobutoxybenzaMide |
161718-85-0 |
C12H14N2O2 |
![カフェイジン酸](/CAS/GIF/54536-15-1.gif) |
カフェイジン酸 |
54536-15-1 |
C8H12N4O3 |
![1-Keto BaMbuterol](/CAS/20211123/GIF/112935-94-1.gif) |
1-Keto BaMbuterol |
112935-94-1 |
C18H27N3O5 |
![デスフルオロエゼチミベ](/CAS/GIF/302781-98-2.gif) |
デスフルオロエゼチミベ |
302781-98-2 |
C24H22FNO3 |
![5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone](/CAS/GIF/59827-93-9.gif) |
5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone |
59827-93-9 |
C13H12BrNO3 |
![Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid)](/CAS/20210111/GIF/39925-19-4.gif) |
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
39925-19-4 |
C8H11N3O6 |
![3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE](/CAS/GIF/104774-87-0.gif) |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
![セルトラリンケトン](/CAS/GIF/124379-29-9.gif) |
セルトラリンケトン |
124379-29-9 |
C16H12Cl2O |
![(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/CAS/20200119/GIF/872980-38-6.gif) |
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
872980-38-6 |
C28H31ClO10 |
![Vinorelbine Impurity DX](/CAS/20211123/GIF/89368-94-5.gif) |
Vinorelbine Impurity DX |
89368-94-5 |
C46H55BrN4O8 |
![1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)
methyl)piperazin-1-yl)ethoxy)acetate compound with 2-
hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)
piperazin-1-yl)ethoxy)acetate (1:1) hydrochloride](/) |
1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)
methyl)piperazin-1-yl)ethoxy)acetate compound with 2-
hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)
piperazin-1-yl)ethoxy)acetate (1:1) hydrochloride |
|
|
![Dapoxetine Impurity 17](/) |
Dapoxetine Impurity 17 |
|
|
![(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール](/CAS/GIF/223251-16-9.gif) |
(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール |
223251-16-9 |
C15H23NO2 |
![4-ヒドロキシプロポホール](/CAS/GIF/1988-10-9.gif) |
4-ヒドロキシプロポホール |
1988-10-9 |
C12H18O2 |
![(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid](/CAS/20130318/GIF/CB82599546.gif) |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
![N1-Methylbenzene-1,2,4-triaMine](/CAS/GIF/60651-29-8.gif) |
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |
![RocuroniuMbroMide iMpurity H](/) |
RocuroniuMbroMide iMpurity H |
|
|
![5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan](/CAS/GIF/64169-45-5.gif) |
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan |
64169-45-5 |
C19H21ClFNO |
![dextroMethorphanone](/) |
dextroMethorphanone |
|
|
![oxiracetaM related substance ISF3886](/CAS/20180808/GIF/120428-80-0.gif) |
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
![Carvedilol IMpurity D](/CAS/GIF/1391052-16-6.gif) |
Carvedilol IMpurity D |
1391052-16-6 |
C39H39N3O6 |
![DL-2-(4-Carboxyphenyl)propionic Acid](/CAS/GIF/67381-50-4.gif) |
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
![ベタメタゾン17-プロピオン酸21-メシル酸](/CAS/GIF/15423-80-0.gif) |
ベタメタゾン17-プロピオン酸21-メシル酸 |
15423-80-0 |
C26H35FO8S |
![12-O-メチルクラリスロマイシン](/CAS/GIF/128940-83-0.gif) |
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
![3(R)-Hydroperoxy Simvastatin](/CAS/GIF/1092716-42-1.gif) |
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
![10-デアセチル-10-オキソバッカチンV](/CAS/GIF/151636-94-1.gif) |
10-デアセチル-10-オキソバッカチンV |
151636-94-1 |
C29H34O10 |
![ドキシルアミン4-ピリジニル異性體](/CAS/GIF/873407-01-3.gif) |
ドキシルアミン4-ピリジニル異性體 |
873407-01-3 |
C17H22N2O |
![Clopidogrel EP IMpurity D](http://CAS/20150408/GIF/1421283-60-4.gif) |
Clopidogrel EP IMpurity D |
1421283-60-4 |
C24H21Cl2NO4S |
![Loratadine IMpurity E](/CAS/20150408/GIF/CB82630382.gif) |
Loratadine IMpurity E |
|
C22H23ClN2O2 |
![Flucloxacillin IMpurity G](/) |
Flucloxacillin IMpurity G |
|
|
![Gefitinib N-Oxide](/CAS/20180808/GIF/847949-51-3.gif) |
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
![Milrinone IMpurity 3](/CAS/20150408/GIF/98293-81-3.gif) |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
![Nicardipine Related CoMpound 4](/CAS/20180808/GIF/123973-71-7.gif) |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
![PraMipexole IMp.BI-II786BS](/) |
PraMipexole IMp.BI-II786BS |
|
|
![Propofol IMpurity E](/) |
Propofol IMpurity E |
|
|
![Solifenacin Related CoMpound 5](/) |
Solifenacin Related CoMpound 5 |
|
|
![TelMisartan BroMo Ethyl Ester](/CAS/20180808/GIF/133085-87-7.gif) |
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
![Tolterodine Lactol IMpurity](/CAS/20180808/GIF/209747-04-6.gif) |
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
![Valsartan N1-Trityl IMpurity](/) |
Valsartan N1-Trityl IMpurity |
|
|
![(3-Carbamoylallyl)trimethylammonium](/CAS/20150408/GIF/857162-57-3.gif) |
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
![N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド](/CAS/GIF/3964-54-3.gif) |
N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド |
3964-54-3 |
C8H8ClNO2 |
![ent-14S-3-Methoxy-17-MethylMorphinan](/CAS/20150408/GIF/1453167-99-1.gif) |
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
![PD 224378](/CAS/GIF/501665-88-9.gif) |
PD 224378 |
501665-88-9 |
C20H35NO11 |
![(rac,syn)-4-Deschloro-sertraline](/CAS/GIF/871838-58-3.gif) |
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
![1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol](/CAS/20150408/GIF/93413-86-6.gif) |
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](/CAS/20150408/GIF/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
![11-Desethyl Irinotecan](/CAS/GIF/103816-16-6.gif) |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
![7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid](/CAS/GIF/56796-16-8.gif) |
7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid |
56796-16-8 |
C15H17N3O7S2 |
![7S-Cefdinir](/CAS/20180808/GIF/178601-89-3.gif) |
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
![Dehydroxy BroMocelecoxib](/CAS/20200515/GIF/170570-75-9.gif) |
Dehydroxy BroMocelecoxib |
170570-75-9 |
C17H13BrF3N3O2S |
![Desethylene Norfloxacin Hydrochloride](/CAS/GIF/75001-77-3.gif) |
Desethylene Norfloxacin Hydrochloride |
75001-77-3 |
C14H16FN3O3 |
![p-(2,3-Epoxypropoxy)benzyl Alcohol](/CAS/20150408/GIF/4204-78-8.gif) |
p-(2,3-Epoxypropoxy)benzyl Alcohol |
4204-78-8 |
C10H12O3 |
![α-Etoposide](/CAS/20211123/GIF/100007-53-2.gif) |
α-Etoposide |
100007-53-2 |
C29H32O13 |
![N-Desmethyl-N-benzyl Sildenafil](/CAS/20140608/GIF/CB82700009.gif) |
N-Desmethyl-N-benzyl Sildenafil |
1446089-82-2 |
C28H34N6O4S |